New Pacing and Defibrillation Technologies

Session Organizer: Michael Eggen, Medtronic

Expand all

Extravascular ICD: Use Conditions and Design Considerations

The Aurora EV-ICD™ system is a first-of-its-kind extravascular defibrillator to treat sudden cardiac arrest and abnormal heart rhythms with defibrillation and antitachycardia pacing (ATP). This talk will introduce the system as well as review some of the early use condition development work.

Matt Hoffman - DMD Speaker

Matt Hoffman

Matt Hoffman received his BBmE degree in Biomedical Engineering from the University of Minnesota and is currently a Sr Principal Scientist at Medtronic.  His research interests include cardiac pacing, tachyarrhythmia and heart failure therapies

Clinical and Patient Perspective on Extravascular ICD

Review of the new EV-ICD system with our clinical experience during the PIVOTAL trial and after FDA approval.

Henri Roukoz - 2023 Clinical Case

Henri Roukoz
University of Minnesota

Dr. Roukoz is an Associate Professor of Medicine and the Section Head for Electrophysiology at the University of Minnesota. Dr Roukoz is also the Director of the Congenital and Complex Arrhythmia program and part of the Cardiac Sarcoidosis international consortium and the U of M sarcoidosis program. His clinical interests include epicardial and endocardial ablation of complex arrhythmias (ventricular tachycardia and atrial fibrillation) and implantation of EP medical devices. 

Dr. Roukoz received his MD from Saint Joseph University in Beirut, Lebanon in 2004, and he completed an internship in internal medicine at the Hotel Dieu de France University Hospital, also in Beirut, in 2005. He did his internal medicine residency training at the Cleveland Clinic from 2005-2008, and completed two fellowships in Cardiology (2008-2011) and Electrophysiology (2011-2013) at the University of Minnesota. He has been on faculty at the University of Minnesota since 2013.

Building the Next Era of Pacing

Advances in leadless pacemaker technology and conduction system pacing has made pacing therapy more physiologic and improved patient outcomes. The Medtronic vision is to design pacing systems that merge our conduction system pacing and leadless pacing platforms to improve patient outcomes and serve new patients. 

This presentation will discuss recent devices and the next innovations that will expand the use of pacing to new populations. Conduction system pacing can enable treatment of a broader range of cardiovascular disease by managing both rate disorders and improving hemodynamics for patients.

Teri Whitman, 2023 Keynote & DMD Awardee

Teri Whitman
Research Director, Medtronic

Teri Whitman, PhD is a Research Director at Medtronic in Cardiac Implantables Research & Technology. Teri has more than 25 years of experience in the medical device industry and leads a team focused on novel cardiac therapies and implant procedures for pacemakers and defibrillators. 

Whitman’s research interests include hemodynamics of arrhythmias, minimally invasive cardiac procedures, and design and delivery of pediatric devices. As a prolific innovator, she holds more than 30 patents. Teri is a Medtronic Bakken and Technical Fellow, a University of Minnesota Institute for Engineering in Medicine (IEM) fellow and serves on the Purdue School of Biomedical Engineering Advisory Board. 

Whitman holds a bachelor’s degree in mechanical engineering from the University of Wyoming. Teri was a National Science Foundation Research Fellow and earned an MS and PhD in Biological Engineering from Purdue University.

Left Bundle Area Pacing

Matthew Olson Allina Health Minneapolis Heart Institute - DMD Speaker

Matthew Olson
Allina Health Minneapolis Heart Institute

Dr. Olson received his biomedical engineering degree from Marquette University and worked in industry prior to his medical training. He is a practicing electrophysiologist in the twin cities at the Minneapolis Heart Institute. 

Session Organizer Bio

Michael Eggen - DMD Conference Session Organizer

Michael Eggen

Dr. Michael Eggen received his PhD in Biomedical Engineering from the University of Minnesota, and is currently a Research Manager and Technical Fellow at Medtronic. His research interests include, heart failure therapies, cardiac pacing and the electrode tissue interface, and the use of isolated heart models for research and development of implantable medical devices. As an industry scientist and adjunct professor, Michael has continued to collaborate with academia in research, medical device innovation, publications, and teaching.